Kurome Therapeutics
ID: 7683259Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
1
Funding Rounds
$15.0m
Money raised
Recent Funding Rounds
Overview
Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Ri** | - | - | - |
| Ma**** Bh****** | - | - | - |
| Ab*** Go**** | - | - | - |
| Sh*** Ma***** | - | - | - |
| Da**** He**** | - | - | - |
Funding series
Funding Series Analysis
The company Kurome Therapeutics has raised a total of $15m in funding over 1 rounds.
Key Insights:
- Kurome Therapeutics Series A round, June 2021: $15m
Industries
Kurome Therapeutics is active in the following industries: